Ollie's (OLLI) Insider: John Swygert Exercises Options, Sells 107,058 Shares
Rhea-AI Filing Summary
Ollie's Bargain Outlet Holdings, Inc. (OLLI) Executive Chairman John W. Swygert reported multiple transactions on 09/22/2025 under a Rule 10b5-1 plan adopted June 23, 2025. He exercised three tranches of employee stock options covering 25,070 shares at $79.89, 54,915 shares at $60.30, and 27,073 shares at $86.03, and subsequently sold 107,058 shares at a weighted average price of $132.87. After these transactions, he beneficially owned 155,258 shares in total, reported as direct ownership.
The filing discloses that some option grants had fully vested by their stated dates and that sale prices ranged from $131.35 to $136.16; the reporting person will provide detailed per-transaction prices upon request.
Positive
- Transactions executed under a Rule 10b5-1 plan, which provides a pre-established framework for insider trades
- Options had fully vested prior to exercise, indicating no acceleration or special vesting treatment
Negative
- Substantial sale of 107,058 shares by the Executive Chairman, which may be perceived negatively by some investors
- Weighted average sale price disclosed without per-trade breakdown; per-transaction prices are only available upon request
Insights
TL;DR: Executive exercised vested options and sold a sizable block under a 10b5-1 plan; ownership remains material.
The filing shows conversion of vested employee options into common stock and a significant open-market sale of 107,058 shares at a weighted average of $132.87. These actions were executed pursuant to a pre-established Rule 10b5-1 plan adopted June 23, 2025, which reduces concerns about opportunistic timing. Post-transaction beneficial ownership is 155,258 shares direct, indicating continued alignment with shareholders despite the sale. The filing provides a weighted average sale price and a price range; detailed per-trade prices are available on request.
TL;DR: Insider sales by the Executive Chairman are material for governance scrutiny, though executed under a documented 10b5-1 plan.
The report documents substantial option exercises followed by market sales totaling 107,058 shares at an indicated weighted average of $132.87. Because the reporting person is Executive Chairman, these transactions are governance-relevant and warrant attention from investors and the board. The presence of a 10b5-1 plan provides procedural defensibility, but the magnitude of disposition relative to prior holdings is significant and should be noted in any assessment of insider liquidity or signaling.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 25,070 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 54,915 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 27,073 | $0.00 | -- |
| Exercise | Common Stock, par value $0.001 per share | 25,070 | $79.89 | $2.00M |
| Exercise | Common Stock, par value $0.001 per share | 54,915 | $60.30 | $3.31M |
| Exercise | Common Stock, par value $0.001 per share | 27,073 | $86.03 | $2.33M |
| Sale | Common Stock, par value $0.001 per share | 107,058 | $132.87 | $14.22M |
Footnotes (1)
- Transactions made pursuant to an agreement adopted on June 23, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.35-136.16, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 20, 2019, subject to continued service through each applicable vesting date. The options vested in their entirety on March 20, 2023. Options vest and become exercisable in 25% installments on each anniversary date of the grant, December 10, 2019, subject to continued service through each applicable vesting date. The options vested in their entirety on December 10, 2023. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 22, 2021, subject to continued service through each applicable vesting date. The options vested in their entirely on March 22, 2025.
FAQ
What did OLLI Executive Chairman John W. Swygert report on Form 4?
Were these trades part of a pre-arranged plan for OLLI insider trading?
Do the option grants have vesting details disclosed?